Nature Communications (Aug 2018)

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

  • S. N. Gettinger,
  • J. Choi,
  • N. Mani,
  • M. F. Sanmamed,
  • I. Datar,
  • Ryan Sowell,
  • Victor Y. Du,
  • E. Kaftan,
  • S. Goldberg,
  • W. Dong,
  • D. Zelterman,
  • K. Politi,
  • P. Kavathas,
  • S. Kaech,
  • X. Yu,
  • H. Zhao,
  • J. Schlessinger,
  • R. Lifton,
  • D. L. Rimm,
  • L. Chen,
  • R. S. Herbst,
  • K. A. Schalper

DOI
https://doi.org/10.1038/s41467-018-05032-8
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 15

Abstract

Read online

Immune checkpoint blockade (ICB) only induces tumour response in a subset of non-small cell lung carcinomas (NSCLC). Here the authors do whole genome sequencing and multiplexed quantitative immunofluorescence on patient samples and identify a “dormant” T-cell signature associated with sensitivity to ICB.